Loading...
•
Sep 30, 2023
ICU Medical Q3 2023 Earnings Report
Reported third quarter results generally in line with previously revised expectations.
Key Takeaways
ICU Medical announced third quarter 2023 financial results with revenue of $553.3 million, compared to $597.9 million in the same period last year. GAAP net income was $7.2 million, or $0.30 per diluted share, compared to a GAAP net loss of $(13.2) million, or $(0.55) per diluted share, for the third quarter of 2022. Adjusted diluted earnings per share was $1.57 as compared to $1.75 for the third quarter of 2022.
Third quarter revenue was $553.3 million, compared to $597.9 million in the same period last year.
GAAP gross profit for the third quarter of 2023 was $183.9 million, as compared to $186.4 million in the same period last year.
GAAP gross margin for the third quarter of 2023 was 33%, as compared to 31% in the same period last year.
Adjusted diluted earnings per share for the third quarter of 2023 was $1.57 as compared to $1.75 for the third quarter of 2022.
Revenue by Segment
Forward Guidance
No forward guidance was provided in the earnings report.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...